The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
Ann Rheum Dis. 2014 Nov 14. pii: annrheumdis-2014-206028. doi: 10.1136/annrheumdis-2014-206028. [Epub ahead of print]
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Ann Rheum Dis. 2014 Nov 14. pii: annrheumdis-2014-206028. doi: 10.1136/annrheumdis-2014-206028. [Epub ahead of print]
Arthritis Rheumatol. 2015;67(2):372–380
Arthritis Rheumatol. 2015;67(1):51–62
Ann Rheum Dis Published Online First 24 April 2014 doi:10.1136/annrheumdis-2013-204143
Clinical and Experimental Immunology doi.10.1111/cei.12234
Tissue Engineering Part A doi:10/1089/ten.TEA.2013.0553
Rheumatology doi:10.1093/rheumatology/ket414
Nature Clinical Practice 2005; 1(1):31-9
Nature Reviews Immunology 2007; 7:429-42
Best Practice & Research Clinical Rheumatology 2010; 24:513-26